IP Verse

Takeda Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Takeda Pharmaceuticals

Explore patent oppositions filed by Takeda Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3481415
Stable Liquid FibrinogenLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESJun 5, 2024
EP3071596
Improved Process For The Preparation Of Immunoglobulin G (Igg)BIO PRODUCTS LABORATORYMay 29, 2019
EP2345425
Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive IggsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESApr 11, 2019

Latest publications and patents of Takeda Pharmaceuticals New

Explore the latest publications and patents granted to Takeda Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Takeda Pharmaceuticals

EP2582812
Jan 24, 2018Novel Modified Release Dosage Forms Of Xanthine Oxidoreductase Inhibitor Or Xanthine Oxidase InhibitorsNo Opposition Filed Within Time Limit

Latest PTAB cases involving Takeda Pharmaceuticals

Discover the latest PTAB cases involving Takeda Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Takeda Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TAKEDA PHARMACEUTICALS3 - - -
BIO PRODUCTS LABORATORY - 1 - -
LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES - 10 - -
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES SOCIETE ANONYME - 2 - -